Abstract
The effect of lithium on serotonin (5-HT)-mediated responses in the brain was assessed by measuring changes in the prolactin (PRL) and growth hormone (GH) responses to l-tryptophan (LTP) in eight normal subjects. On the 4th day of lithium treatment the PRL responses were significantly enhanced, and this enhancement was still apparent after 20 days' treatment. In contrast, GH responses to LTP were not altered. Lithium had no effect on platelet 5-HT content, platelet imipramine binding and platelet 5-HT receptor binding. The ability of lithium to enhance some aspects of brain 5-HT function may be important in its mode of action in manic-depressive illness and may be particularly relevant to its potentiation of the antidepressant effect of tricyclic antidepressants.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson IM, Cowen PJ (1986) Clomipramine enhances prolactin and growth hormone responses to l-tryptophan. Psychopharmacology 89:131–133
Blier P, De Montigny C (1985) Short term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. Eur J Pharmacol 113:69–77
Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303–305
Charney DS, Heninger GR, Reinhard JF, Sternberg DE, Hafstead KM (1982) The effect of intravenous l-tryptophan on prolactin and growth hormone and mood in healthy subjects. Psychopharmacology 77:217–222
Coppen AJ (1967) The biochemistry of affective disorder. Br J Psychiatr 113:1237–1264
Cowen PJ, Anderson IM (1986) In: Deakin JFW, Freeman H (eds) Recent advances in the biology of depression. Royal College of Psychiatrists special publication
Cowen PJ, Gadhvi H, Gosden B, Kolakowska T (1985) Responses of prolactin and growth hormone to l-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics. Psychopharmacology 86:164–169
Cowen PJ, Geaney DP, Schächter M, Green AR, Elliott JM (1986) Desmethylimipramine treatment in normal subjects: effects on neuroendocrine responses to l-tryptophan and platelet 5-HT-related receptors. Arch Gen Psychiatry 43:61–67
De Montigny C, Cournoyer G, Morissetti R, Langlois R, Caillé G (1983) Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Arch Gen Psychiatry 40:1327–1334
Denckla WD, Dewey HK (1961) The determination of tryptophan in plasma, liver and urine. J Lab Clin Med 69:160–169
Geaney DP, Schächter M, Elliott JM, Grahame-Smith DG (1984) Characterisation of [3H] lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur J Pharmacol 97:87–93
Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753
Grahame-Smith DG, Green AR (1974) The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibitors. Br J Pharmacol 52:19–26
Harrison-Read PE (1981) Behavioural studies with lithium in rats: implications for animal models of mania and depression. In: Hrdina PU, Singhal RL (eds) Neuroendocrine regulation and altered behaviour. London: Croom Helm
Harrison-Read PE (1986) Chronic lithium treatment in rats has different effects on motor responses mediated by 5-HT1 and 5-HT2 receptors. Proceedings of the British Pharmacological Society, Winter Meeting, P 175
Heninger GR, Charney DS (1983) Impaired serotonergic function in depressed patients: augmentation by antidepressant treatment and lithium. Neurosci Abstr 9:305–308
Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment refractory depression. Arch Gen Psychiatry 40:1335–1342
Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression: prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 41:398–402
Knapp S, Mandell AJ (1973) Short- and long-term lithium administrations: effect on the brain's serotonergic biosynthetic systems. Science 180:645–647
MacIndoe JH, Turkington RW (1973) Stimulation of human prolactin secretion by intravenous l-tryptophan. J Clin Invest 52:1972–1978
Maggi A, Enna SJ (1980) Regional alterations in rat brain neurotransmitter systems following chronic lithium treatment. J Neurochem 34:888–892
Meltzer HY, Simonovic M, Sturgeon RO, Fang US (1981) Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels. Acta Psychiatr Scand 63:106–121
Meltzer HY, Wiita B, Tricou BJ, Simonovic M, Fang US, Manov G (1982) Effects of serotonin precursors and serotonin agonists on plasma hormone levels. In: Ho BT (ed) Serotonin in biological psychiatry. New York, Raven Press
Meltzer HY, Umberkoman-Wiita B, Robertson A, Tricou B, Lowy M, Perline R (1984a) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry 41:336–374
Meltzer HY, Lowy M, Robertson A, Goodnick P, Perline R (1984b) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effects of antidepressants and lithium carbonate. Arch Gen Psychiatry 41:391–397
Muhlbauer HO (1984) The influence of fenfluramine stimulation on prolactin plasma levels in lithium long-term-treated manic-depressive patients and healthy subjects. Pharmacopsychiatry 17:191–193
Murphy DL, Campbell IC, Costa JL (1978) The brain serotonergic system in the affective disorders. Prog Neuropsychopharmacol 2:1–31
Paul SM, Rehavi M, Rice KL, Ittah Y, Skolnick P (1981) Does high affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelet? Life Sci 26:2753–2766
Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct serotonin receptors with different physiological functions. Science 212:827–829
Prange AJ (1974) l-Tryptophan in mania: contribution to a permissive hypothesis in affective disorders. Arch Gen Psychiatry 30:56–62
Rehavi M, Paul SM, Skolnick P, Goodwin P (1980) Demonstration of high-affinity binding sites for 3H-imipramine in human brain. Life Sci 26:2273–2279
Sangdee C, Franz DN (1980) Lithium enhancement of 5-HT transmission induced by 5-HT precursors. Biol Psychiatry 15:59–75
Siever LJ, Murphy DL, Slater S, de la Vega E, Lippen S (1984) Plasma prolactin following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in despression. Life Sci 34:1029–1039
Slater S, de la Vega CG, Skyler J, Murphy DL (1976) Plasma prolactin stimulation by fenfluramine and amphetamine. Psychopharmacol Bull 12:26–27
Swann AC, Heninger GR, Roth RH, Maas JW (1981) Differential effects of short- and long-term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci 28:347–354
Treiser SL, Cascio CS, O'Donohue TL, Kellar K (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213:1529–1531
Tricklebank MD (1985) The behavioural responses to 5-HT receptor agonists and subtypes of the central 5-TH receptor. TIPS 6:403–407
Wood K, Swade C, Abou-Saleh MT, Coppen A (1985) Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients. J Affect Dis 8:69–72
Yamada K, Furukawa T (1979) Serotonergic function in mouse head twitches induced by lithium and reserpine. Psychopharmacology 61:255–260
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glue, P.W., Cowen, P.J., Nutt, D.J. et al. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology 90, 398–402 (1986). https://doi.org/10.1007/BF00179198
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00179198